Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma

PT Otsuka Indonesia140 enrolled

Overview

The purpose of this study is to compare the efficacy and safety of nebule procaterol with nebule salbutamol in the treatment of moderate acute asthma.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

140

Conditions

Moderate Acute Asthma

Interventions

Procaterol, SalbultamolDRUG

Eligibility

Sex: ALLMin age: 15 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with moderate acute asthma according to Global Initiative for Asthma (GINA) 1998 (Appendix 1). Patients with moderate acute asthma according to Modified Global Initiative for Asthma (GINA) 1998 (Patients with asthma score 5 - 11; PEFR ≤ 80% predicted) 2. Patients of both gender aged 15 to 60 years 3. Patients still have the ability to undergo examinations and give written informed consent Exclusion Criteria: 1. Pregnant and lactating women 2. Smokers 3. Patients with heart disease, hyperthyroidism, diabetes mellitus, COPD or other chronic diseases 4. Patients with signs of severe infections

Locations (1)

University of Indonesia/ Persahabatan Hospital

Jakarta, Indonesia

Outcomes

Primary Outcomes

Difference 5% from baseline in peak expiratory flow rate (PEFR)

Time frame: 3 times every 20 minutes (at 0, 20 and 40 minutes)

Secondary Outcomes

Difference 5% from baseline in asthma score

Time frame: 3 times every 20 minutes (at 0, 20 and 40 minutes)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.